Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
Year: 2019
Type: article
Study design: Observational Study
Source: Clinical Rheumatology
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Pfizer, National Cancer Institute
OpenAlex ID: W2995731560
